Danone Launches 5,200 M² Research and Innovation Center in Shanghai

Danone officially launched a 5,200 m² research and innovation center in Shanghai on Nov. 2, advancing its work on nutritional solutions for early life, healthy aging, and longevity.

A centerpiece of the complex is the 900 m² Danone OneBiome Lab, the group’s third such site following openings in Paris-Saclay and Singapore. Isabelle Esser, chief research, innovation, quality and food safety officer, noted that the unit uses bacterial DNA extraction and analysis to decode individual gut profiles influenced by age, diet, and lifestyle.

Alongside the laboratory, the hub incorporates a 700 m² pilot plant and a 300 m² science experience and consumer engagement space. This integrated footprint enables Danone to pair consumer feedback with sensory testing, prototyping, packaging design, and digital health tech development under one roof.

Targeting Formula and Healthy Aging

The technical work focuses on two ends of China’s demographic curve: infant nutrition and healthy longevity. In infant milk formula, researchers examine human breast milk composition among Chinese mothers to reformulate Danone’s Aptamil product lines to match natural gut flora development.

For older consumers, the Shanghai team is working on products under lines like Ganmai, a brand Danone rolled out with timed probiotic fibre powders aimed at immune and digestive maintenance. The company had previously established an exploratory research venture with Qingdao University three years ago to study microbiome changes across life stages.

“Some of the most important scientific areas on which we at Danone are investing are related to gut health and to biotics,”

Said Isabelle Esser, chief research, innovation, quality and food safety officer at Danone.

Competing on Science in a Shrinking Baby Market

Danone faces a structural squeeze in China’s infant formula trade. Falling national birth rates have tightened total volumes across the sector, forcing international formula makers into direct shelf competition against domestic champions such as China Feihe.

Foreign dairy brands can no longer rely purely on imported prestige to clear inventory in lower-tier cities. Winning supermarket shelf space and mother-and-baby store distribution now requires hyper-localised scientific claims, especially around gut tolerance, digestion, and ingredient profiles matching local mothers’ milk.

Localised trial work also speeds regulatory filings, meaning on-the-ground pilot facilities cut the lead time between laboratory formulation and commercial retail distribution.

Building Out Regional Digital Health Tools

The Shanghai hub also takes over digital health software testing designed to tie retail customers into the brand’s ecosystem. Danone previously rolled out diagnostic applications from its Singapore lab, including digital iron monitors, infant growth trackers, and stool analysis tools that guide parents toward specific formulas.

Taous Lassel, vice president for research and innovation in Asia-Pacific and China, leads the regional R&D digital and artificial intelligence team operating out of the site.